NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

there were a number of patients that responded to treatment[Direct].

Well, I do not remember that.

Saying a patient lived longer than some formula that treats early prostate the same as late glio is kind of meaningless. Some will always live longer.

"Immune responses" have never been demonstrated to be anything other than, well an immune response. Just give the patient a live flue virus would do that.

As far as the study designated secondary endpoint, RECIST immune response, they have never reported any.

Have you read the paper on the trial results? The one that Dr B said last year at ASCO was in process? I guess it takes time to get results published on a 40 patient P1 that completed 3 years ago.